Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-22T21:34:37.139Z Has data issue: false hasContentIssue false

Chapter 5 - Pain Drugs

Published online by Cambridge University Press:  19 October 2021

Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

Chapter 5 compares the mechanism of opiates to the mechanisms of non-opiate drugs that are also effective in treating many types of pain disorders. Whereas opiates are effective for decreasing acute pain, they also affect many other areas of the brain in ways that may not be optimal for many patients with chronic pain. Chapter 5 introduces drugs that can be highly effective in treating pain disorders, along with some tips and pearls on dosing and prescribing.

In most cases, a single drug is unlikely to relieve all pain. Therefore, combinations of drugs based on complementary mechanisms of action will ultimately alleviate the greatest amount of pain. The drugs presented in this chapter may not work well for people who have been on opiates for some time or who continue to take opiates, as opiates can decrease the effectiveness of other drugs. The ideas presented in this chapter are intended to encourage prescribers to treat patients early and in ways that may prevent or reduce the need for chronic opiate treatment, so as to encourage the greatest level of remission and achieve the highest quality of life.

Lidocaine is effective for acute nociceptive pain, and is also approved for the treatment of postherpetic neuropathic pain. It is available in a variety of formulations, most commonly as a patch or gel.

Anti-inflammatory agents such as cyclooxygenase (COX)- 2 inhibitors can be effective in a wide variety of pain states associated with inflammation, including presumably several types of neuropathic pain (see Figures 2.14 and 2.15). Cyclooxygenase- inhibiting nitric oxide donating drugs (CINODs) may also be effective for pain, with decreased gastrointestinal damage, providing a potential benefit for patients that require long-term anti-inflammatory treatment.

Because of their purported progressive nature, pain disorders that are caught early enough can be largely treated with NSAIDs, COX-2 inhibitors, or CINODs.

Particularly in the treatment of osteoarthritic pain and chronic lower back pain, TCAs have been a treatment of choice. However, their wide-ranging side effects and low tolerability profile have led researchers and clinicians to seek other options. While TCAs remain commonly prescribed for chronic painful disorders, other treatments may prove to be more holistically effective.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Pain Drugs
  • Stephen M. Stahl, University of California, San Diego
  • Illustrated by Nancy Muntner
  • Edited by Sara Ball
  • Book: Stahl's Illustrated Chronic Pain and Fibromyalgia
  • Online publication: 19 October 2021
  • Chapter DOI: https://doi.org/10.1017/9781139192507.006
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Pain Drugs
  • Stephen M. Stahl, University of California, San Diego
  • Illustrated by Nancy Muntner
  • Edited by Sara Ball
  • Book: Stahl's Illustrated Chronic Pain and Fibromyalgia
  • Online publication: 19 October 2021
  • Chapter DOI: https://doi.org/10.1017/9781139192507.006
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Pain Drugs
  • Stephen M. Stahl, University of California, San Diego
  • Illustrated by Nancy Muntner
  • Edited by Sara Ball
  • Book: Stahl's Illustrated Chronic Pain and Fibromyalgia
  • Online publication: 19 October 2021
  • Chapter DOI: https://doi.org/10.1017/9781139192507.006
Available formats
×